Improving cancer detection using advanced PET imaging techniques
Characterizing, optimizing, and harmonizing cancer detection with PET imaging
['FUNDING_R01'] · UNIVERSITY OF WASHINGTON · NIH-11015828
This study is looking at ways to make it easier and more accurate to find early-stage cancers using special imaging technology, so that doctors can give better diagnoses and help patients get the care they need sooner.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF WASHINGTON (nih funded) |
| Locations | 1 site (SEATTLE, UNITED STATES) |
| Trial ID | NIH-11015828 on ClinicalTrials.gov |
What this research studies
This research focuses on enhancing the detection and diagnosis of early-stage cancers through the use of positron emission tomography (PET) imaging with fluorine 18–fluorodeoxyglucose (FDG). By optimizing imaging parameters and employing advanced algorithms, including artificial intelligence, the project aims to improve the accuracy of cancer detection across various imaging systems. The methodology involves systematic evaluations of how different imaging technologies affect the identification of cancerous tissues, ultimately aiming to standardize and harmonize these methods across different clinical settings. This could lead to more reliable cancer diagnoses and better patient outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals at risk for cancer or those undergoing evaluation for potential cancer diagnosis.
Not a fit: Patients with advanced-stage cancers or those who are not undergoing imaging for cancer detection may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve early cancer detection, leading to better survival rates for patients.
How similar studies have performed: Previous research has shown promising results in enhancing cancer detection through improved imaging techniques, indicating that this approach has potential for success.
Where this research is happening
SEATTLE, UNITED STATES
- UNIVERSITY OF WASHINGTON — SEATTLE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: KINAHAN, PAUL E. — UNIVERSITY OF WASHINGTON
- Study coordinator: KINAHAN, PAUL E.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.